![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Ecopetrol
EC
Coinbase
COIN
MicroStrategy
MSTR
Petroleo Brasileiro SA Petrobras
PBR
MARA Holdings
MARA
US Stock MarketDetailed Quotes
XLO Xilio Therapeutics
- 1.070
- +0.115+12.04%
Close Jan 2 16:00 ET
- 1.050
- -0.020-1.87%
Post 20:01 ET
48.92MMarket Cap-0.69P/E (TTM)
1.070High0.965Low267.35KVolume0.978Open0.955Pre Close273.34KTurnover1.22%Turnover RatioLossP/E (Static)45.72MShares1.93052wk High2.33P/B23.37MFloat Cap0.50052wk Low--Dividend TTM21.84MShs Float27.950Historical High--Div YieldTTM11.00%Amplitude0.490Historical Low1.022Avg Price1Lot Size
Xilio Therapeutics Stock Forum
Sign in to post a comment
$Xilio Therapeutics (XLO.US)$Disappointing! I expected a much bigger increase following the announcement from Gilead.
1
$Xilio Therapeutics (XLO.US)$ watching Closely here 👌
1
$Kaixin Holdings (KXIN.US)$ $AppTech Payments (APCX.US)$ $Alpha Modus Holdings (AMOD.US)$ $Color Star Technology (ADD.US)$ $BioNexus Gene Lab (BGLC.US)$ $Ocean Biomedical (OCEA.US)$ $Xilio Therapeutics (XLO.US)$ $Humacyte (HUMA.US)$ $Aadi Biosciences (AADI.US)$ $Aditxt (ADTX.US)$ $Nvni Group (NVNI.US)$ $Psyence Biomedical (PBM.US)$ $Aptose Biosciences (APTO.US)$
📊⚡️📊
📊⚡️📊
6
3
NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
7. I DO NOT give buy or sell advice
8. COH (cash on hand); AH (after hours): RTH (regular trading hours)
$Aadi Biosciences (AADI.US)$ PR AH 12/...
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
7. I DO NOT give buy or sell advice
8. COH (cash on hand); AH (after hours): RTH (regular trading hours)
$Aadi Biosciences (AADI.US)$ PR AH 12/...
68
32
7
$Xilio Therapeutics (XLO.US)$ Gilead Sciences Acquires 7.85M Xilio Therapeutics Shares At $1.04 Each, Raising Ownership To Over 10%, Along With 6.1M Pre-Funded Warrants Capped At 19.99% Ownership
1
$Xilio Therapeutics (XLO.US)$
Xilio Therapeutics to Present Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI
Thursday, 19th December at 7:30 am
Announces preliminary Phase 1 data for XTX301, a tumor-activated IL-12, demonstrating an improved tolerability profile over historical data for rhIL-12, with no dose-limiting toxicities
Completed additional pri...
Xilio Therapeutics to Present Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI
Thursday, 19th December at 7:30 am
Announces preliminary Phase 1 data for XTX301, a tumor-activated IL-12, demonstrating an improved tolerability profile over historical data for rhIL-12, with no dose-limiting toxicities
Completed additional pri...
No comment yet
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Jackson Frolic : Maybe next week? BioAge had a multi day rise after weaker news. The Gilead purchase was significant validation of the technology IMO